VALUE OF THE FREE LIGHT CHAIN ANALYSIS IN THE CLINICAL EVALUATION OF RESPONSE IN MULTIPLE MYELOMA PATIENTS RECEIVING ANTI-MYELOMA THERAPY

被引：0
|
作者：
Hansen, T. [1 ]
Nielsen, C. [2 ]
Pedersen, T. [3 ]
Ambi, B. [3 ]
Abildgaard, N. [3 ]
机构：
[1] Univ Southern Denmark, Odense C, Denmark
[2] Dept Biochem, Esbjerg, Denmark
[3] Dept Hematol, Esbjerg, Denmark
来源：
HAEMATOLOGICA | 2012年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1582
引用
收藏
页码：624 / 625
页数：2
相关论文
共 50 条
  • [21] Serum free light chain analysis and urine immunofixation electrophoresis in patients with multiple myeloma
    Nowrousian, MR
    Brandhorst, D
    Sammet, C
    Kellert, M
    Daniels, R
    Schuett, P
    Poser, M
    Mueller, S
    Ebeling, P
    Welt, A
    Bradwell, AR
    Buttkereit, U
    Opalka, B
    Flasshove, M
    Moritz, T
    Seeber, S
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 8706 - 8714
  • [22] IgD multiple myeloma: Clinical, biological features and prognostic value of the serum free light chain assay
    Djidjik, R.
    Lounici, Y.
    Chergeulaine, K.
    Berkouk, Y.
    Mouhoub, S.
    Chaib, S.
    Belhani, M.
    Ghaffor, M.
    PATHOLOGIE BIOLOGIE, 2015, 63 (4-5): : 210 - 214
  • [23] RETRACTED ARTICLE: Subsequent anti-myeloma therapy after idecabtagene vicleucel treatment in patients with relapsed/refractory multiple myeloma: A single center analysis
    Ricardo D. Parrondo
    Keren Sam
    Ahsan Rasheed
    Victoria Alegria
    Taimur Sher
    Vivek Roy
    Asher Chanan-Khan
    Sikander Ailawadhi
    Blood Cancer Journal, 12
  • [24] Utility of Serum Free Light Chain Measurements in Multiple Myeloma Patients Not Achieving Complete Response
    Moustafa, Muhamad Alhaj
    Rajkumar, S. Vincent
    Dispenzieri, Angela
    Buadi, Francis
    Gertz, Morie
    Lacy, Martha
    Kapoor, Prashant
    Hayman, Suzanne
    Dingli, David
    Kyle, Robert
    Kumar, Shaji
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S238 - S238
  • [25] Utility of Serum Free Light Chain Measurements in Multiple Myeloma Patients Not Achieving Complete Response
    Moustafa, Muhamad Alhaj
    Rajkumar, S. Vincent
    Dispenzieri, Angela
    Buadi, Francis K.
    Gertz, Morie A.
    Lacy, Martha Q.
    Kapoor, Prashant
    Hayman, Suzanne R.
    Dingli, David
    Kyle, Robert
    Kumar, Shaji
    BLOOD, 2014, 124 (21)
  • [26] Light chain multiple myeloma: when the response will it be evaluated by serum free light chains?
    Corre, Jill
    Avet-Loiseau, Herve
    Hematologie, 2016, 22 (06): : 393 - 394
  • [27] Potential pitfalls of serum free light chain analysis to assess treatment response for multiple myeloma
    Abbi, Kamal Kant Singh
    Silverman, Margarida
    Farooq, Umar
    Tricot, Annick
    Dozeman, Lindsey
    Nadiminti, Kalyan
    Krasowski, Matthew D.
    Tricot, Guido J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 174 (04) : 536 - 540
  • [28] Potential Pitfalls of Serum Free Light Chain Analysis to Assess Treatment Response for Multiple Myeloma
    Abbi, Kamal Kant Singh
    Tricot, Guido J.
    Silverman, Margarida
    Nadiminti, Kalyan
    Krasowski, Matthew
    BLOOD, 2015, 126 (23)
  • [29] Bone healing in multiple myeloma: a prospective evaluation of the impact of first-line anti-myeloma treatment
    Hinge, Maja
    Andersen, Kristian T.
    Lund, Thomas
    Jorgensen, Henrik B.
    Holdgaard, Paw C.
    Ormstrup, Tina E.
    Ostergaard, Lone L.
    Plesner, Torben
    HAEMATOLOGICA, 2016, 101 (10) : E419 - E422
  • [30] Changes in serum free light chain and biochemical markers in patients with multiple myeloma receiving bortezomib treatment.
    Min, Chang-Ki
    Eom, Ki-Seong
    Lee, Seok
    Lee, Jong-Wook
    Min, Woo-Sung
    Park, Chong-Won
    Kim, Chun-Choo
    Kim, Myungshin
    Lim, Jihyang
    Kim, Yonggoo
    Han, Kyungja
    BLOOD, 2006, 108 (11) : 346B - 346B
12345